David J. Matson
Fulcrum Therapeutics (United States)(US)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Ion channel regulation and function, Nicotinic Acetylcholine Receptors Study, Neuropeptides and Animal Physiology, Ion Channels and Receptors
Most-Cited Works
- → Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain(2014)160 cited
- → Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators(2016)123 cited
- → Inflammation-Induced Reduction of Spontaneous Activity by Adjuvant: A Novel Model to Study the Effect of Analgesics in Rats(2006)97 cited
- → Characterization of N-(Adamantan-1-ylmethyl)-5-[(3 R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation(2008)77 cited
- → Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain(2010)65 cited
- → Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain(2011)54 cited
- → Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7(2017)52 cited
- → Discovery of Novel 6,6-Heterocycles as Transient Receptor Potential Vanilloid (TRPV1) Antagonists(2010)37 cited
- → New frontiers in assessing pain and analgesia in laboratory animals(2008)25 cited
- → The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement(2017)21 cited